Back to Search
Start Over
Reviva Pharmaceuticals announces grant of European patent on brilaroxazine
- Source :
- The Fly. July 9, 2024
- Publication Year :
- 2024
-
Abstract
- Reviva Pharmaceuticals announced European Patent EP3244896 has been granted by the European Patent Office, EPO, covering use of brilaroxazine for the treatment of PH, adding to its existing patent protection [...]
- Subjects :
- Patent law
Pulmonary hypertension
Business
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.800635399